Approval for the xmi rapid exchange (xmi-rx) catheter, a modification of the xmi-otw catheter.  The device, as modified, will be marketed under the trade name possis angiojet xmi rapid exchange rheolytic thrombectomy system, and is indicated for removing thrombus in the treatment of patients with symptomatic coronary artery or saphenous vein graft lesions in vessels >=2.0 mm in diameter prior to balloon angioplasty or stent placement.